NuVasive Past Earnings Performance
Past criteria checks 2/6
NuVasive's earnings have been declining at an average annual rate of -49.5%, while the Medical Equipment industry saw earnings growing at 12.3% annually. Revenues have been growing at an average rate of 2.1% per year. NuVasive's return on equity is 4.7%, and it has net margins of 3.4%.
Key information
-49.5%
Earnings growth rate
-49.7%
EPS growth rate
| Medical Equipment Industry Growth | 12.9% |
| Revenue growth rate | 2.1% |
| Return on equity | 4.7% |
| Net Margin | 3.4% |
| Last Earnings Update | 31 Dec 2022 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How NuVasive makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 22 | 1,202 | 40 | 634 | 99 |
| 30 Sep 22 | 1,199 | -20 | 636 | 98 |
| 30 Jun 22 | 1,174 | -40 | 628 | 98 |
| 31 Mar 22 | 1,159 | -37 | 624 | 94 |
| 31 Dec 21 | 1,139 | -64 | 610 | 93 |
| 30 Sep 21 | 1,129 | -26 | 594 | 89 |
| 30 Jun 21 | 1,153 | 2 | 594 | 86 |
| 31 Mar 21 | 1,062 | -50 | 563 | 84 |
| 31 Dec 20 | 1,051 | -37 | 547 | 80 |
| 30 Sep 20 | 1,069 | -9 | 563 | 77 |
| 30 Jun 20 | 1,065 | -4 | 570 | 75 |
| 31 Mar 20 | 1,153 | 61 | 596 | 73 |
| 31 Dec 19 | 1,168 | 65 | 611 | 72 |
| 30 Sep 19 | 1,146 | 48 | 593 | 70 |
| 30 Jun 19 | 1,127 | 52 | 581 | 67 |
| 31 Mar 19 | 1,116 | 49 | 574 | 65 |
| 31 Dec 18 | 1,102 | 12 | 576 | 62 |
| 30 Sep 18 | 1,085 | 24 | 568 | 57 |
| 30 Jun 18 | 1,060 | 41 | 553 | 55 |
| 31 Mar 18 | 1,038 | 42 | 546 | 53 |
| 31 Dec 17 | 1,027 | 82 | 540 | 50 |
| 30 Sep 17 | 1,027 | 64 | 547 | 51 |
| 30 Jun 17 | 1,019 | 35 | 554 | 50 |
| 31 Mar 17 | 996 | 53 | 549 | 50 |
| 31 Dec 16 | 962 | 37 | 534 | 48 |
| 30 Sep 16 | 906 | 42 | 510 | 44 |
| 30 Jun 16 | 867 | 51 | 489 | 40 |
Quality Earnings: NUVA * has high quality earnings.
Growing Profit Margin: NUVA * became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NUVA *'s earnings have declined by 49.5% per year over the past 5 years.
Accelerating Growth: NUVA * has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: NUVA * has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-3%).
Return on Equity
High ROE: NUVA *'s Return on Equity (4.7%) is considered low.